Jeff Ji Zhu
CIK 1791135 · View on SEC EDGAR ↗
Insider
First SEC filing: Oct. 15, 2019 · Latest: Oct. 15, 2019
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 41 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
41 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 13, 2024 | CBT | S | 14,566 | $113.25 | $1,649,600 | 69,449 Direct | -17.34% | Disposed | -24.7% (price as of 2026-08-21) |
| Aug. 27, 2024 | CBT | S | 13,511 | $103.85 | $1,403,117 | 82,489 Direct | -14.07% | Disposed | -17.8% (price as of 2026-08-21) |
| Aug. 27, 2024 | CBT | S | 200 | $104.41 | $20,882 | 82,289 Direct | -0.24% | Disposed | -18.3% (price as of 2026-08-21) |
| Aug. 26, 2024 | CBT | S | 1,201 | $106.19 | $127,534 | 96,000 Direct | -1.24% | Disposed | -19.7% (price as of 2026-08-21) |
| Feb. 13, 2024 | CBT | S | 18,384 | $80.50 | $1,479,912 | 97,201 Direct | -15.91% | Disposed | 6.0% (price as of 2026-08-21) |
| Feb. 13, 2024 | CBT | S | 14,434 | $80.00 | $1,154,720 | 97,201 Direct | -12.93% | Disposed | 6.6% (price as of 2026-08-21) |
| Feb. 13, 2024 | CBT | S | 22,415 | $79.38 | $1,779,303 | 97,201 Direct | -18.74% | Disposed | 7.5% (price as of 2026-08-21) |
| Feb. 15, 2022 | CBT | S | 13,763 | $70.85 | $975,109 | 76,783 Direct | -15.20% | Disposed | 20.4% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 19, 2025 | CBT | Employee Stock Option (Right to Buy) | Common Stock (22,544) | $59.76 | Nov. 18, 2035 | 22,544 | Acquired |
| Nov. 8, 2024 | CBT | Employee Stock Option (Right to Buy) | Common Stock (8,563) | $114.99 | Nov. 7, 2034 | 8,563 | Acquired |
| Feb. 13, 2024 | CBT | Employee Stock Option (Right to Buy) | Common Stock (18,384) | $62.24 | Nov. 9, 2027 | 18,384 | Disposed |
| Feb. 13, 2024 | CBT | Employee Stock Option (Right to Buy) | Common Stock (14,434) | $50.46 | Nov. 10, 2026 | 14,434 | Disposed |
| Feb. 13, 2024 | CBT | Employee Stock Option (Right to Buy) | Common Stock (22,415) | $39.54 | Nov. 11, 2025 | 22,415 | Disposed |
| Nov. 10, 2023 | CBT | Employee Stock Option (Right to Buy) | Common Stock (13,402) | $74.40 | Nov. 9, 2033 | 13,402 | Acquired |
| Nov. 11, 2022 | CBT | Employee Stock Option (Right to Buy) | Common Stock (13,984) | $73.84 | Nov. 10, 2032 | 13,984 | Acquired |
| Feb. 15, 2022 | CBT | Stock Options | Cabot Corp (13,763) | $35.25 | Nov. 8, 2022 | 13,763 | Acquired |
| Nov. 12, 2021 | CBT | Employee Stock Option (Right to Buy) | Common Stock (20,297) | $58.27 | Nov. 11, 2031 | 20,297 | Acquired |
| Nov. 13, 2020 | CBT | Employee Stock Option (Right to Buy) | Common Stock (32,507) | $40.97 | Nov. 12, 2030 | 32,507 | Acquired |
| Nov. 8, 2019 | CBT | Employee Stock Option (Right to Buy) | Common Stock (26,217) | $50.23 | Nov. 7, 2029 | 26,217 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 6 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 15, 2019 | CBT | Common Stock | — | Direct |
| Oct. 15, 2019 | CBT | Employee Stock Option (Right to Buy)→ Common Stock (13,763) | 13,763 | Direct |
| Oct. 15, 2019 | CBT | Employee Stock Option (Right to Buy)→ Common Stock (22,415) | 22,415 | Direct |
| Oct. 15, 2019 | CBT | Employee Stock Option (Right to Buy)→ Common Stock (14,434) | 14,434 | Direct |
| Oct. 15, 2019 | CBT | Employee Stock Option (Right to Buy)→ Common Stock (18,384) | 18,384 | Direct |
| Oct. 15, 2019 | CBT | Employee Stock Option (Right to Buy)→ Common Stock (24,475) | 24,475 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CBT
President and President, Performance Chemicals Segment & Asia Pacific Region| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $546,631 | — | $682,356 | $367,514 | $267,026 | — | $1,062,763 | $2,926,290 |
| 2022 | $517,426 | — | $601,230 | $323,737 | $540,131 | — | $1,046,492 | $3,029,016 |
| 2021 | $501,762 | — | $584,969 | $314,928 | $599,000 | — | $958,427 | $2,959,086 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.